Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Smooth pursuit disorders.

C Pierrot-Deseilligny1, B Gaymard

  • 1Service de Neurologie, Unité INSERM 289, Hôpital de la Salpêtrière, Paris, France.

Bailliere'S Clinical Neurology
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.

Scientific reports·2017
Same author

Oculomotor Impairments in Developmental Dyspraxia.

Cerebellum (London, England)·2016
Same author

[American Academy of Neurology, Washington, 18-25 April 2015].

Revue neurologique·2015
Same author

[American Academy of Neurology, Philadelphia, 26 April-3 May, 2014].

Revue neurologique·2014
Same author

Effects of structural and functional cerebellar lesions on sensorimotor adaptation of saccades.

Experimental brain research·2013
Same author

[American Academy of Neurology, San Diego, 16-23 March 2013].

Revue neurologique·2013
Same journal

Remyelination in demyelinating disease.

Bailliere's clinical neurology·1999
Same journal

Other immunomodulatory therapies in multiple sclerosis.

Bailliere's clinical neurology·1999
Same journal

Copolymer-1.

Bailliere's clinical neurology·1999
Same journal

Interferon beta 1a.

Bailliere's clinical neurology·1999
Same journal

Treatment of multiple sclerosis with interferon beta 1b.

Bailliere's clinical neurology·1999
Same journal

The cause and management of bladder, sexual and bowel symptoms in multiple sclerosis.

Bailliere's clinical neurology·1999
See all related articles

Smooth pursuit eye movements, crucial for tracking targets, involve complex pathways from the cortex to the brainstem. Lesion studies reveal specific brain regions critical for maintaining smooth pursuit function.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Motor Control

Background:

  • Smooth pursuit eye movements are essential for visual tracking in frontal-eyed species.
  • This system is involved in foveal smooth pursuit, the rapid component of optokinetic nystagmus (OKN) slow phase, and vestibulo-ocular reflex (VOR) suppression.

Purpose of the Study:

  • To elucidate the anatomical pathways and neural circuitry underlying smooth pursuit eye movements.
  • To identify key brain regions and their projections involved in both lateral and vertical smooth pursuit.

Main Methods:

  • Review of anatomical projections and physiological data related to smooth pursuit.
  • Analysis of lesion studies in various brain regions, including the cortex, pontine nuclei, cerebellum, and brainstem nuclei.

Related Experiment Videos

Main Results:

  • Cortical areas project to pontine nuclei (DLPN), then through the midbrain to the cerebellum (flocculus and posterior vermis).
  • Floccular and vermal lesions impair ipsilateral and bilateral smooth pursuit, respectively.
  • Pathways involve inhibitory projections to vestibular nuclei (MVN, y-group, SVN) and excitatory projections to abducens nucleus.

Conclusions:

  • The smooth pursuit system relies on intricate, multi-decussating pathways involving the cortex, pons, cerebellum, and brainstem.
  • Specific cerebellar regions (flocculus, vermis) and brainstem nuclei are critical for accurate eye velocity encoding and target tracking.
  • Further investigation may be needed to fully delineate the inhibitory circuitry preceding floccular Purkinje cells.